Description of Ophthalmic Pharmaceutical and Device Start-Up Companies

Publisher： Karger

E-ISSN： 1423-0259|54|1|6-9

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.54, Iss.1, 2015-05, pp. : 6-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of verteporfin therapy: A collaboration between pharmaceutical companies, device manufacturers and clinical investigators

By Huber Gustave   Levy Julia  

Seminars in Ophthalmology, Vol. 16, Iss. 4, 2001-12 ,pp. : 213-217

Informa Healthcare

Access to resources Recommend Favorite

Hydroxyl Radical Scavenging Activity of a New Ophthalmic Viscosurgical Device

By Maugeri Francesco   Maltese Adriana   Ward Keith   Bucolo Claudio  

Current Eye Research, Vol. 32, Iss. 2, 2007-02 ,pp. : 105-111

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of a Mobile Diabetic Retinopathy Screening Campaign to Encourage Diabetics to Undergo Regular Ophthalmic Follow-Up

By  

Ophthalmic Research, Vol. 52, Iss. 4, 2014-11 ,pp. : 206-211

Karger

Access to resources Recommend Favorite

Fluid Temperature at the Corneal Endothelium during Phacoemulsification: Comparison of an Ophthalmic Viscosurgical Device and Balanced Salt Solution Using the Finite Element Method

By  

Ophthalmic Research, Vol. 43, Iss. 4, 2009-12 ,pp. : 173-178

Karger

Access to resources Recommend Favorite

Neuro-ophthalmic manifestations of hemangiopericytoma

By Lee Andrew   Eggenberger Eric   Galetta Steven   Kerrison John   Miller Neil   Kirby Patricia   Wall Michael   Hitchon Patrick   Kardon Randy  

Seminars in Ophthalmology, Vol. 19, Iss. 3-4, 2004-09 ,pp. : 95-100

Informa Healthcare

Access to resources Recommend Favorite